CIRSE Annual Congress

September 13-17 | Barcelona, Spain

Pioneering progress

September 13-17 | Barcelona, Spain

Pioneering progress

September 13-17 | Barcelona, Spain

September 13-17 | Barcelona, Spain

September 13-17 | Barcelona, Spain

Pioneering progress
Slider
ProgrammeSneak peeksConcept and rational behind vessel preparation: why bother?

Concept and rational behind vessel preparation: why bother?

Three things you will learn at my lecture

  1. Conventional balloon angioplasty causes severe vessel wall distress and dissection by fracturing and displacing plaque within the arterial layers.
  2. Vessel preparation is particularly crucial in younger claudicants compared to older patients with CLTI, where stenting thresholds are lower. Therefore, a more sophisticated endovascular approach is essential in the claudication group to preserve future treatment options.
  3. Data indicate that utilizing scoring balloons for vessel preparation minimizes severe dissection and recoil, thereby decreasing the need for stents and optimizing drug delivery, especially in calcified and resistant lesions.

Prof. Stavros Spiliopoulos
Speaker bio
 

Add this session to your calendar!

“Is it time to move on from conventional angioplasty and stenting of the femoropopliteal arteries to more sophisticated plaque modification techniques?”

Femoropopliteal arterial lesions, often characterized by significant calcifications, present substantial challenges for endovascular interventions. Traditional balloon angioplasty can lead to suboptimal results due to significant dissection and inadequate acute luminal gain. Vessel preparation refers to the techniques used to modify or debulk plaque to optimize the vessel’s condition before the chosen endovascular treatments such as drug-coated angioplasty or stenting. The goal of vessel preparation is to optimize the outcome of the primary intervention by removing or modifying plaque, achieve the optimal acute luminal gain with minimum vessel trauma, and create a more uniform and receptive surface for drug delivery.

Scoring balloons utilize embedded or external, longitudinal or circumferential scoring elements, such as nitinol wires, that exert focused force on the plaque during inflation, offering a more controlled and less traumatic approach to plaque modification. As a result, the combination of low-pressure angioplasty and targeted controlled fractures within the plaque facilitates a more uniform expansion and reduces the risk of dissection. Moreover, plaque modification may enhance drug penetration from DCBs into the vessel wall but also protect the subsequent DCB application from rupturing during inflation when facing hard atherosclerotic lesions.

Considering the indications and patient selection criteria, vessel preparation takes on heightened importance in younger patients presenting with claudication. This contrasts with older patients suffering from CLTI, where the urgency of preventing a major amputation often leads to a lower threshold for stenting. In the younger claudication group, preserving future treatment options necessitates a more meticulous endovascular approach.

Regarding the technical challenges of endovascular treatment, achieving an optimal angioplasty result presents a significant challenge in calcified occlusions when subintimal lesion crossing is required and atherectomy is contraindicated. In such scenarios, high-pressure balloon angioplasty alone is often insufficient, and a more sophisticated approach is required, especially for severely calcified, non-stent-friendly lesions. (Figure 1). The main indications for vessel preparation using scoring balloons in femoropopliteal lesions include calcified and/or resistant fibrotic stenosis and occlusions, especially following subintimal or retrograde popliteal crossing where atherectomy is not an option.

Several scoring balloon catheters are currently available for femoropopliteal use and include the AngioSculpt™ by Philips, the APERTA NSE™ by NIPRO, the Scoreflex‡ NC by Abbott, the Tri-Wedge by APR Medtech, and the UntrascoreTM by BD.  The Chocolate™* PTA balloon by Medtronic could also be included in the wider scoring balloon category as it is a semi-compliant balloon encased in a nitinol-constraining structure, designed to create a controlled, less traumatic inflation.

Published data on vessel prep using scoring balloons include several non-randomized studies. [2] Horie K. et al. reported positive outcomes regarding luminal gain and dissections following scoring vs. plain balloon angioplasty in a propensity score matching study (84 matched pairs). [3] More recently Haraguchi T. et al. reported superior technical success when a newer technology scoring balloon vs. conventional scoring balloons was used in another propensity score-matched analysis (50 matched pairs). [4] While there isn’t a definitive large-scale randomized trial directly comparing scoring versus conventional balloon angioplasty for femoropopliteal lesions, the available evidence suggests that scoring balloons may offer advantages in terms of technical success and lesion preparation, especially in calcified or complex lesions. [1, 5] A low complication rate has been recently reported following the use of a specific scoring balloon in the femoropopliteal segment, mainly associated with a device tip break, balloon rupture, and withdrawal difficulty in severely calcified vessels. Interestingly, balloon rupture was noted at a higher rate amongst calcified vessels (60.6% vs 14.8%), p= < 0.001, and in cases of SFA angioplasty (39.4% vs 11.3%), p = <0.001. [6] Although scoring balloons are recommended for calcified and/or fibrotic femoropopliteal lesions, in a recent Interdisciplinary Expert Opinion Statement [7], robust comparative safety and efficacy data on both immediate and long-term outcomes versus conventional balloons is lacking and warrants investigation in dedicated randomized controlled trials.

In conclusion, vessel preparation using scoring balloons is a valuable technique for optimizing outcomes in femoropopliteal arterial interventions. Careful patient selection, meticulous technique, and ongoing research are essential to maximize the benefits of this technology.

Figure 1. Treatment of complex femoropopliteal disease in an 70-year-old male with intermittent claudication: Severely calcified femoropopliteal tandem stenosis and mid popliteal (P2) CTO treated with scoring balloon preparation and Sirolimus-coated balloon (SCB) angioplasty. (a) Initial angiogram revealing tandem stenosis and a proximal popliteal CTO. (b) Subintimal crossing achieved with a re-entry device (arrow) due to extensive (360-degree) calcification, as visualized on fluoroscopy. (c) Gradual scoring balloon inflation for vessel preparation (up to 12 atm), with visible indentation on the balloon indicating the hard calcified plaque. (d) Application of low-pressure sirolimus-coated balloons (e, f) Excellent final angiographic outcome following low-pressure SCB angioplasty.

 

Stavros Spiliopoulos

National and Kapodistrian University of Athens, Athens/GR

Prof. Spiliopoulos is a Professor of Diagnostic and Interventional Radiology at the University of Athens, Greece, and practices at the 2nd Department of Radiology, "Attikon" University General Hospital, in which he is the Head of the Vascular Interventional Radiology Department. His clinical expertise encompasses vascular and non-vascular IR, as well as interventional oncology procedures. He holds the European Board of Interventional Radiology (EBIR) certification, including the designation of Endovascular Specialist (EBIR-ES). He is also a Fellow of the Cardiovascular and Interventional Society of Europe (FCIRSE). Prof. Spiliopoulos currently serves as president of the vascular sub-committee of the European Society of Radiology (ESR) and is a member of the ESR Interventional Radiology and Robotics Subcommittee. He also holds the positions of treasurer for both the Greek Society of Interventional Radiology and the Greek Society of Cardiovascular Research, and serves on the board of the Hellenic College of Radiology. He has a prolific publication record, with over 220 peer-reviewed articles published in prestigious journals such as The Lancet, JACC, Radiology, European Radiology, and Stroke, along with 20 international book chapters. He has delivered over 150 invited lectures at national and international congresses and has been recognized with over 35 international awards and distinctions for his research contributions. Prof. Spiliopoulos is actively involved in research as a primary and co-investigator in numerous multicenter studies. His primary research interests include the endovascular treatment of peripheral arterial disease and dialysis vascular access, personalized vascular medicine, and loco-regional treatments of solid organ malignancies. He serves as an associate editor for three PubMed-indexed scientific journals and is on the editorial boards of six international peer-reviewed journals. With nearly 20 years of experience in all facets of interventional radiology, Prof. Spiliopoulos regularly performs both routine and emergency procedures. He is an integral part of a large tertiary university hospital's 24/7 on-call service and maintains a busy outpatient clinic.

 

References

  1. Spiliopoulos S, Karamitros A, Reppas L, Brountzos E. Novel balloon technologies to minimize dissection of peripheral angioplasty. Expert Rev Med Devices. 2019;16(7):581-588.
  2. Lugenbiel I, Grebner M, Zhou Q, et al. Treatment of femoropopliteal lesions with the AngioSculpt scoring balloon – results from the Heidelberg PANTHER registry. Vasa. 2018;47(1):49-55.
  3. Horie K, Tanaka A, Taguri M, Inoue N. Impact of Scoring Balloons on Percutaneous Transluminal Angioplasty Outcomes in Femoropopliteal Lesions. J Endovasc Ther. 2020;27(3):481-491.
  4. Haraguchi T, Tsujimoto M, Otake R, Kashima Y, Sato K, Fujita T. Propensity score-matched analysis of six-month outcomes of paclitaxel-coated balloons combined with UltraScore balloons versus conventional scoring balloons for femoropopliteal lesions. Diagn Interv Radiol. 2023;29(3):535-541.
  5. Hong H, Park UJ, Roh YN, Kim HT. Predictive Factors of Severe Dissection after Balloon Angioplasty for Femoropopliteal Artery Disease. Ann Vasc Surg. 2021;77:109-115.
  6. Dayco JS, Osman H, Almas T, et al. Major Complications and Failure Modes of the Angiosculpt Scoring Balloon Catheter: Analysis of the MAUDE Database. Curr Probl Cardiol. 2023;48(4):101557.
  7. Korosoglou G, Schmidt A, Lichtenberg M, et al. Global Algorithm for the Endovascular Treatment of Chronic Femoropopliteal Lesions: An Interdisciplinary Expert Opinion Statement. JACC Cardiovasc Interv. 2025;18(5):545-557.